The ability of liquid particle counters to generate reportable results from one sample leads to its greater adoption in clinical research and medical device manufacturing.
New York, NY -- (SBWIRE) -- 09/07/2017 -- Liquid particle counters market is expected to witness exponential growth attributed to the increasing use of cleanroom with controlled environment for R&D and pharmaceutical products manufacturing processes. The ability of liquid particle counters to generate reportable results from one sample leads to its greater adoption in clinical research and medical device manufacturing. Moreover, growing biotechnology and pharmaceutical industry would contribute to the growth of liquid particle counters market. Similarly, due to tremendously developing healthcare infrastructure and increasing government expenditure in clinical trials and drug development, the market is expected to witness significant growth during the forecast period. However, stringent regulatory approvals and inadequate reimbursements policies might restrict the market growth.
Based on the component, the liquid particle counters market is segmented into devices, software and services. Devices includes actual particle counter equipment with sensors that detects contamination in the given sample. These devices works in combination with software, which allows manufacturers to manipulate or control the sample size and its analysis. Based on the application, the market is segmented into testing and monitoring. In the testing application, mostly small volume liquid particle counters are used, whereas, during monitoring, high volume liquid particle counters are used. Based on technique, the market is further segmented into light obscuration and light scattering. Light obscuration techniques is widely being used for the measurement of relatively large particle i.e. 1.5 microns to 150 microns, whereas, light scattering is used for small particle detection measured under 1.5 microns.
Global liquid particle counter market is experiencing significant growth attributed to increased demand for high volume liquid particle counter and analyzers, which is prime requirement for pharmaceutical research and drug development. In addition, the need for cautious monitoring of contamination during drug development to avoid the adverse effect on final product further drives the market growth. Moreover, upcoming new technologies, which monitors nanoparticles and drinking water quality would likely to bring additional revenue to the market in coming years.
Geographically liquid particle counter market is classified into regions viz. North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America and Europe will remain key markets for liquid particle counter market due to the presence of large pharmaceutical companies and clinical research organizations. Asia Pacific is anticipated to register positive growth owing to rising government's investment in life science and pharmaceutical sector and expanding clinical research industry in the region.
Request for more detailed information (TOC And Sample) : https://www.persistencemarketresearch.com/samples/14416
Some of the key players in the liquid particle counter are Beckman Coulter, Inc., Biotest Diagnostics Corp, Brookhaven Instruments Corp, Chemtrac Systems, Inc., Climet Instruments Company, GLI International, Inc., Horiba Instruments, Inc., Lighthouse Worldwide Solutions, Inc., Particle Measuring Systems, Inc. to name a few. Key players are adopting product launch and distribution agreement as few of their developmental strategies in order to maintain the market presence and gain the momentum.